ID: ALA129326

Max Phase: Preclinical

Molecular Formula: C13H14N2O2

Molecular Weight: 230.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc(CCCc2ccccc2)[nH]n1

Standard InChI:  InChI=1S/C13H14N2O2/c16-13(17)12-9-11(14-15-12)8-4-7-10-5-2-1-3-6-10/h1-3,5-6,9H,4,7-8H2,(H,14,15)(H,16,17)

Standard InChI Key:  JDCXDGHZXKZHQL-UHFFFAOYSA-N

Associated Targets(non-human)

Hydroxycarboxylic acid receptor 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 230.27Molecular Weight (Monoisotopic): 230.1055AlogP: 2.28#Rotatable Bonds: 5
Polar Surface Area: 65.98Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.19CX Basic pKa: 0.39CX LogP: 3.07CX LogD: -0.38
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.83Np Likeness Score: -0.70

References

1. van Herk T, Brussee J, van den Nieuwendijk AM, van der Klein PA, IJzerman AP, Stannek C, Burmeister A, Lorenzen A..  (2003)  Pyrazole derivatives as partial agonists for the nicotinic acid receptor.,  46  (18): [PMID:12930155] [10.1021/jm030888c]

Source